Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01867580 · ClinicalTrials.gov registry record · NA
A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement
A NA study of Wounds and Injuries, sponsored by KCI USA.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
- 7
- Study locations
NCT01867580: Completed NA study of Wounds and Injuries, sponsored by KCI USA.
NCT01867580 is a NA study of Wounds and Injuries that has completed, run by KCI USA. The registered enrollment target is 181 participants, below the 497-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (64% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01867580, a NA study of Wounds and Injuries, has completed, sponsored by KCI USA.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to examine the effectiveness of the Veraflo with Prontosan vs VAC in wounds that require operative debridement.
Primary Outcome
Debridement in this outcome refers to surgical removal of non viable tissue performed in an operating room
Conditions Studied
Interventions
- DEVICE V.A.C.Ulta with Prontosan instillation
- DEVICE V.A.C.Ulta without instillation
Study Locations (7)
Pennsylvania
- St. Luke's University Hospital - Bethlehem
- University of Pennsylvania Health System - Philadelphia
District of Columbia
- Medstar Georgetown University Hospital - Washington D.C.
Florida
- University of Miami Miller School of Medicine - Miami
Illinois
- Northwestern University - Chicago
Massachusetts
- Brigham and Women's Hospital - Boston
Texas
- University of Texas Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT01867580 record still lists
NCT01867580 is an interventional study that assigns participants to a tested intervention. The registered 181 participants enrollment target is mid-sized for trials with a published cap, below the 497-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Wounds and Injuries appearing as the primary indexed condition, and to 2 interventions - of which V.A.C.Ulta with Prontosan instillation is the first listed.
NCT01867580 lists 7 locations in 6 states (Pennsylvania, District of Columbia, Florida).
Frequently Asked Questions
What is clinical trial NCT01867580 about?
NCT01867580 is a clinical study titled "A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement". The purpose of this study is to examine the effectiveness of the Veraflo with Prontosan vs VAC in wounds that require operative debridement.
What is the current status of trial NCT01867580?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2013-05. Estimated completion is 2015-11.
What conditions does trial NCT01867580 study?
This clinical trial studies the following conditions: Wounds and Injuries.
What interventions are being tested in trial NCT01867580?
The interventions under investigation include: V.A.C.Ulta with Prontosan instillation (DEVICE), V.A.C.Ulta without instillation (DEVICE).
Who is sponsoring clinical trial NCT01867580?
This trial is sponsored by KCI USA, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01867580 being conducted?
This trial has 7 study locations across District of Columbia, Florida, Illinois, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds and Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01867580's enrollment target sits among peer trials
181 13th of 27 higher than 15 of 27 other Wounds and Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wounds and Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Giving Reduced Fluid in Children After Trauma
RECRUITING · NA
-
Blood Flow Restriction Training After Patellar INStability
RECRUITING · NA
-
Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
RECRUITING · NA
-
Pediatric Prehospital Airway Resuscitation Trial
RECRUITING · NA
-
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
RECRUITING · NA
-
Brief Intervention for Alcohol Use Among Injured Patients
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578392 · 181 participants · NA
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
- NCT05597891 · 181 participants · NA
Endovascular Engineering ENGULF Study
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia